Envoy Medical, Inc.
COCH
$0.84
$0.045.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.40% | -55.91% | 14.89% | 30.50% | 42.27% |
| Total Depreciation and Amortization | 56.07% | 58.82% | 42.86% | 30.08% | 55.86% |
| Total Amortization of Deferred Charges | 26.51% | 58.63% | 110.21% | 208.31% | -- |
| Total Other Non-Cash Items | 8.80% | 157.34% | -85.92% | -82.69% | -91.27% |
| Change in Net Operating Assets | 111.69% | 139.99% | 147.41% | 24.31% | -203.66% |
| Cash from Operations | 29.58% | 25.07% | 21.80% | -0.91% | -188.32% |
| Capital Expenditure | 134.33% | 91.04% | -332.02% | -540.52% | -787.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 134.33% | 91.04% | -332.02% | -540.52% | -787.28% |
| Total Debt Issued | 0.00% | 114.29% | 81.82% | 100.00% | 25.00% |
| Total Debt Repaid | -30.49% | -45.01% | -94.51% | -187.57% | -- |
| Issuance of Common Stock | 66.91% | -84.32% | -100.00% | 1,444.04% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -32.79% | -- | -- | -- | -- |
| Other Financing Activities | 354.61% | -80.84% | -80.84% | -80.84% | -96.30% |
| Cash from Financing | 18.13% | -17.97% | -29.88% | -8.40% | -46.93% |
| Foreign Exchange rate Adjustments | 120.00% | 120.00% | 140.00% | -66.67% | 28.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.01% | 111.03% | -90.42% | -68.65% | -176.50% |